Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew W. Foehr currently holds 309,376 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew W. Foehr has been a net seller of LGND stock. They have purchased $8.5M and sold $32.6M worth of shares.
Matthew W. Foehr's most recent insider trade was on Apr 7, 2026, when they sold 36,459 shares at $0.00 per share.
Matthew W. Foehr serves as Executive at LIGAND PHARMACEUTICALS INC (LGND). They have executed 222 insider transactions totaling $41.0M over their tenure at the company.
Matthew W. Foehr holds the position of Executive at LIGAND PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Matthew W. Foehr has shown a selling trading pattern, with $8.5M in total purchases and $32.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew W. Foehr was on May 12, 2023, when they purchased $1.5M worth of OABI shares. This transaction involved 440,000 shares at $3.40 per share.
Matthew W. Foehr currently owns 309,376 shares of LIGAND PHARMACEUTICALS INC (LGND), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew W. Foehr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew W. Foehr has 222 Form 4 filings on record as an insider at LIGAND PHARMACEUTICALS INC.
Set alerts for Matthew W. Foehr and 40,000+ other insiders.